These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5492405)

  • 1. [Yellow fever vaccine production and control. II. Freeze-drying of yellow fever vaccine. A. The development of a chamber apparatus].
    Pichl H; Voss H; Tetzlaff J; Bölke H
    Zentralbl Bakteriol Orig; 1970; 215(3):404-28. PubMed ID: 5492405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of 2 yellow fever vaccines administered by pressure injector without needle].
    Gateff C; Robin Y; Labusquiere R; Le Gonidec G; Lemarinier G; Bradley M
    Med Trop (Mars); 1972; 32(2):193-7. PubMed ID: 5082185
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of protein content by biuret method during production of Yellow Fever Vaccine.
    Shrivastaw KP; Singh S; Sharma SB; Sokhey J
    Biologicals; 1995 Dec; 23(4):299-300. PubMed ID: 8825858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-drying equipment.
    Le Floc'h L
    Dev Biol Stand; 1976 Oct; 36():131-7. PubMed ID: 1030411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simultaneous vaccination against hepatitis A and yellow fever].
    Receveur MC; Quiniou JM; Delprat P; Monlun E; Lehner V; Le Bras M
    Bull Soc Pathol Exot; 1993; 86(5 Pt 2):406-9. PubMed ID: 7819790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is there an alternative to the amaril 17D vaccine?].
    Saluzzo JF
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):436. PubMed ID: 11000959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reemergence of yellow fever in West Africa: lessons from the past, advocacy for a control program].
    Moreau JP; Girault G; Dramé I; Perraut R
    Bull Soc Pathol Exot; 1999 Dec; 92(5):333-6. PubMed ID: 10690471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 13. Yellow fever vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jan; 32(52):679-82, 687-8. PubMed ID: 6419048
    [No Abstract]   [Full Text] [Related]  

  • 14. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rev Roum Virol; 1993; 44(1-2):3-7. PubMed ID: 8043476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of the Arilvax; yellow fever vaccine.
    Barrett AD
    Expert Rev Vaccines; 2004 Aug; 3(4):413-20. PubMed ID: 15270646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observations on the 17 D virus vaccine against yellow fever, applied by cutaneous scarification].
    Groot H; Gast-Galvis A
    Rev Invest (Guadalajara); 1965 Apr; 5(1):5-25. PubMed ID: 5829925
    [No Abstract]   [Full Text] [Related]  

  • 18. Yellow fever outbreak in Ipetu-Ijesa: response after mass vaccination.
    Adu FD; Adeniji JA; Tomori O; Adelasoye A
    Rom J Virol; 1993; 44(1-2):3-7. PubMed ID: 9702244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.
    Mantel N; Aguirre M; Gulia S; Girerd-Chambaz Y; Colombani S; Moste C; Barban V
    J Virol Methods; 2008 Jul; 151(1):40-6. PubMed ID: 18501437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe post-vaccination reaction to 17D yellow fever vaccine in Nigeria.
    Oyelami SA; Olaleye OD; Oyejide CO; Omilabu SA; Fatunla BA
    Rev Roum Virol; 1994; 45(1-2):25-30. PubMed ID: 7756161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.